Select a section from the left sidebar
Bryoniaoside B
- Family: Plantae - Cucurbitaceae
- Kingdom: Plantae
-
Class: Terpenoid
- Subclass: Triterpene
Canonical Smiles | OC[C@H]1O[C@@H](O[C@H]2CC[C@@H]3C(=CC[C@@H]4[C@@]3(C)[C@@H](O)C[C@]3([C@@]4(C)CC[C@@H]3[C@](C/C=C/C(O[C@@H]3O[C@@H](C)[C@@H]([C@H]([C@H]3O)O)O)(C)C)(O)C)C)C2(C)C)[C@@H]([C@H]([C@@H]1O)O)O |
---|---|
InChI | InChI=1S/C42H70O13/c1-21-29(45)31(47)34(50)36(52-21)55-37(2,3)16-10-17-41(8,51)25-15-18-39(6)26-13-11-22-23(42(26,9)27(44)19-40(25,39)7)12-14-28(38(22,4)5)54-35-33(49)32(48)30(46)24(20-43)53-35/h10-11,16,21,23-36,43-51H,12-15,17-20H2,1-9H3/b16-10+/t21-,23+,24+,25-,26-,27-,28-,29-,30+,31+,32-,33+,34+,35-,36-,39-,40+,41-,42-/m0/s1 |
InChIKey | YPMVCQPCLRLUQR-OEGUSSEYSA-N |
Formula | C42H70O13 |
HBA | 13 |
HBD | 9 |
MW | 783.01 |
Rotatable Bonds | 9 |
TPSA | 218.99 |
LogP | 2.07 |
Number Rings | 6 |
Number Aromatic Rings | 0 |
Heavy Atom Count | 55 |
Formal Charge | 0 |
Fraction CSP3 | 0.9 |
Exact Mass | 782.48 |
Number of Lipinski Rule Violations | 3 |
# | Species | Family | Kingdom | NCBI Taxonomy ID |
---|---|---|---|---|
1 | Bryonia cretica | Cucurbitaceae | Plantae | 61884 |
Showing of synonyms
Bryoniaoside B
- Matsuda H, Nakashima S, et al. (2010). Cucurbitane-Type Triterpenes with Anti-proliferative Effects on U937 Cells from an Egyptian Natural Medicine, Bryonia cretica: Structures of New Triterpene Glycosides, Bryoniaosides A and B. Chemical & pharmaceutical bulletin, 2010, 58(5), 747-51. [View] [PubMed]
No compound-protein relationship available.
SMILES: O1CCCCC1OCC=CCCC(CC2)C(C23)CCC4C3CC=C5C4CCC(C5)OC6CCCCO6
Level: 2
Mol. Weight: 783.01 g/mol
SMILES: O1CCCCC1OCC=CCCC2CCC(C23)C4C(CC3)C5C(=CC4)CCCC5
Level: 1
Mol. Weight: 783.01 g/mol
SMILES: C1CCC(C12)CCC3C2CC=C4C3CCC(C4)OC5CCCCO5
Level: 1
Mol. Weight: 783.01 g/mol
SMILES: C1CCC(C12)CCC3C2CC=C4C3CCCC4
Level: 0
Mol. Weight: 783.01 g/mol
SMILES: C1CCOCC1
Level: 0
Mol. Weight: 783.01 g/mol
No bioactivities available.
Absorption
- Caco-2 (logPapp)
- -6.33
- Human Oral Bioavailability 20%
- Non-Bioavailable
- Human Intestinal Absorption
- Absorbed
- Madin-Darby Canine Kidney
- 3.880
- Human Oral Bioavailability 50%
- Non-Bioavailable
- P-Glycoprotein Inhibitor
- Inhibitor
- P-Glycoprotein Substrate
- Substrate
- Skin Permeability
- 1253.52
Distribution
- Blood-Brain Barrier (CNS)
- -
- Blood-Brain Barrier
- Penetrable
- Fraction Unbound (Human)
- 0.900
- Plasma Protein Binding
- 106.3
- Steady State Volume of Distribution
- -
Metabolism
- Breast Cancer Resistance Protein
- Non-Inhibitor
- CYP 1A2 Inhibitor
- Non-Inhibitor
- CYP 1A2 Substrate
- Non-Substrate
- CYP 2C19 Inhibitor
- Non-Inhibitor
- CYP 2C19 Substrate
- Substrate
- CYP 2C9 Inhibitor
- Non-Inhibitor
- CYP 2C9 Substrate
- Non-Substrate
- CYP 2D6 Inhibitor
- Non-Inhibitor
- CYP 2D6 Substrate
- Non-Substrate
- CYP 3A4 Inhibitor
- Non-Inhibitor
- CYP 3A4 Substrate
- Substrate
- OATP1B1
- Inhibitor
- OATP1B3
- Non-Inhibitor
Excretion
- Clearance
- 2.410
- Organic Cation Transporter 2
- Non-Inhibitor
- Half-Life of Drug
- -
Toxicity
- AMES Mutagenesis
- Safe
- Avian
- Safe
- Bee
- Toxic
- Bioconcentration Factor
- -29.100
- Biodegradation
- Safe
- Carcinogenesis
- Safe
- Crustacean
- Safe
- Liver Injury I (DILI)
- Safe
- Eye Corrosion
- Safe
- Eye Irritation
- Safe
- Maximum Tolerated Dose
- -1.400
- Liver Injury II
- Safe
- hERG Blockers
- Toxic
- Daphnia Maga
- 6.460
- Micronucleos
- Safe
- NR-AhR
- Safe
- NR-AR
- Safe
- NR-AR-LBD
- Safe
- NR-Aromatase
- Safe
- NR-ER
- Safe
- NR-ER-LBD
- Safe
- NR-GR
- Safe
- NR-PPAR-gamma
- Safe
- NR-TR
- Safe
- T. Pyriformis
- -2277299.810
- Rat (Acute)
- 4.600
- Rat (Chronic Oral)
- 3.750
- Fathead Minnow
- 2881.160
- Respiratory Disease
- Toxic
- Skin Sensitisation
- Safe
- SR-ARE
- Safe
- SR-ATAD5
- Safe
- SR-HSE
- Safe
- SR-MMP
- Toxic
- SR-p53
- Safe
General Properties
- Boiling Point
- 253230.550
- Hydration Free Energy
- -2.920
- Log(D) at pH=7.4
- 3.820
- Log(P)
- 2.53
- Log S
- -3.27
- Log(Vapor Pressure)
- -8210.67
- Melting Point
- 229.5
- pKa Acid
- -17.81
- pKa Basic
- 6.88